A new case of ?￠????de novo?￠???? BRCA1 mutation in a patient with early-onset breast cancer

摘要

Key Clinical Message Most of the de novo BRCA1/2 mutations have been identified in patients with early-onset breast cancer and without family history of the disease. The identification of these alterations could play a prominent role in the prevention and treatment strategies and may influence clinical management of patients.